Lower Plasma Melatonin Levels Predict Worse Long-Term Survival in Pulmonary Arterial Hypertension

Exogenous melatonin has been reported to be beneficial in the treatment of pulmonary hypertension (PH) in animal models. Multiple mechanisms are involved, with melatonin exerting anti-oxidant and anti-inflammatory effects, as well as inducing vasodilation and cardio-protection. However, endogenous l...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Zongye, Klein, Theo, Geenen, Laurie W., Tu, Ly, Tian, Siyu, van den Bosch, Annemien E., de Rijke, Yolanda B., Reiss, Irwin K. M., Boersma, Eric, Duncker, Dirk J., Boomars, Karin A., Guignabert, Christophe, Merkus, Daphne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7287676/
https://www.ncbi.nlm.nih.gov/pubmed/32344923
http://dx.doi.org/10.3390/jcm9051248

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7287676/
https://www.ncbi.nlm.nih.gov/pubmed/32344923
http://dx.doi.org/10.3390/jcm9051248

Ejemplares similares